| |
Lesion SUVmax
|
P-value
|
|---|
|
Mean ± SD
|
Median (IQR)
|
|---|
|
Pathology
| | | |
|
• IDC(n=36)
|
3.96±3.1
|
2.85(3.33)
|
=0.258#
|
|
• ILC(n=3)
|
2.41±2.98
|
0.8
|
|
• Other (n=1)
|
1
| |
|
Menopausal State
| | | |
|
• Pre- (n=19)
|
14.55 ± 2.1
|
13 (6)
|
0.003*
|
|
• Post- (n=21)
|
7.45 ± 1.0
|
7 (2)
|
|
Disease Stage
| | | |
|
• I & II (n=27)
|
8.79 ± 1.1
|
7 (2)
|
= 0.017*
|
|
• III & IV (n=13)
|
15.06 ± 2.9
|
14 (5)
|
|
ER-Receptors
| | | |
|
Positive (n=31)
|
9.12 ± 5.7
|
7 (6)
|
= 0.010**
|
|
Negative (n=9)
|
16.70 ± 9.6
|
12.5 (11)
|
|
PR-Receptors
| | | |
|
Positive (n=24)
|
9.13 ± 6.2
|
7 (5)
|
= 0.113**
|
|
Negative (n=16)
|
13.37 ± 9.7
|
9 (8.5)
|
|
Her2-neu Receptors
| | | |
|
Positive (n=14)
|
12.35 ± 5.8
|
13 (9.5)
|
=0.089**
|
|
Negative (n=26)
|
10.01 ± 8.9
|
7 (6.5)
|
|
Tumor grad
|
|
GI (n=5)
|
3.69±1.4
|
3.1(2.6)
| |
|
GII (n=18)
|
9.43±6.11
|
6.85(11.08)
|
=0.002#
|
|
GIII (n=15)
|
15.03±9.20
|
11.11(13.4)
| |
|
Molecular subtype
| | | |
|
Luminal A (n=10)
|
5.88±4.9
|
4.18(5.06)
|
0.007#
|
|
Luminal B (n=19)
|
10.93±5.55
|
8.4(9)
|
|
Her2neu over expression (n=4)
|
8.03±5.24
|
7.98(9.13)
|
|
Triple negative (n=7)
|
19.19±11.86
|
21.6(17.67)
|
|
Axillary LN State
|
|
Positive (n=27)
|
12.80 ± 8.6
|
10 (8.5)
|
= 0.016**
|
|
Negative(n=13)
|
6.73 ± 4.1
|
6.5 (6)
|
- *Independent t-test
- **Mann Whitney U
- # Kruskal Wallis test
